AML-468 Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: “Real-Life” Data Versus the RATIFY Study
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01203-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
585
Citations
13
h-index
13
i10-index
María José Sayas is an academic researcher from Hospital Universitario Doctor Peset. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Acute Lymphoblastic Leukemia research. The author has an h-index of 13, co-authored 46 publications.
https://doi.org/10.1016/s2152-2650(24)01203-5
https://doi.org/10.1016/s2152-2650(24)00511-1
Click to start Chat